1-(2-Chlorophenyl)-1h-pyrazol-3-amine, 95%, 250mg

1H,1H-Pentafluoropropyl acrylate contains 100 ppm 4-tert-butylcatechol as inhibitor, 97.0%, 25g

2-[3-(1H-imidazol-1-yl)propoxy]benzaldehyde hydrochloride, 95.0%, 1g

Benzyl 4-(piperidin-4-yl)piperazine-1-carboxylate, 5g

1,2-Dierucoyl-sn-glycero-3-phosphocholine>95.0%(HPLC)250mg

N-(4-(4-(Trifluoromethoxy)phenyl)pyrimidin-2-yl)-1H-indazol-5-amine, 98+%, 50mg

3,9'-BICARBAZOLE, 95%, 5g

Cyclobutyl 2-(4-fluorophenyl)ethyl ketone, 97.0%, 1g

2-Chloro-5-(trifluoromethyl)phenylboronic acid, 95.0%, 10g

4-[2-(trans-4-Propylcyclohexyl)ethyl]cyclohexanone>98.0%(GC)1g

3-Benzyloxyphenyl isothiocyanate, 98.0%, 250mg

2-(3-Benzoylthioureido)-5,5-dimethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid, 97.0%, 1mg

4-(2-methoxyphenyl)piperidine;hydrochloride, 97%, 1g